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The structure of an iridolactone isolated from Valeriana
laxi¯ora was established as (4R,4aR,6S,7S,7aS)-6-hydroxy-7-
hydroxymethyl-4-methylperhydrocyclopenta[c]pyran-1-one
chloroform solvate, C10H16O4CHCl3. The two rings are cis-
fused. The -lactone ring adopts a slightly twisted half-chair
conformation with approximate planarity of the lactone group
and the cyclopentane ring adopts an envelope conformation.
The hydroxy group, the hydroxymethyl group and the methyl
group all have  orientations. The absolute con®guration was
determined using anomalous dispersion data enhanced by the
adventitious inclusion of a chloroform solvent molecule.
Hydrogen bonding, crystal packing and ring conformations
are discussed in detail.
Comment
The alarming increase in the number of deaths due to tuber-
culosis (TB) and growing resistance to existing drugs has
created an urgent need for the identi®cation of leads for new
antimycobacterial drugs. There were 8.3 million new cases of
tuberculosis in the year 2000 alone, and this number is on the
rise. Approximately one death every 15 s is due to TB,
resulting in a total of about two million TB deaths annually
(Corbett et al., 2003). Strains of TB resistant to existing drugs
are found in nearly every country (Cohn et al., 1997), and a
percentage of these strains are resistant to multiple drugs,
making effective treatment extremely expensive and, in many
cases, impossible. Most patients in developing countries, where
TB is an even bigger problem than elsewhere in the world,
cannot afford expensive drug treatments. There have been no
new drugs developed for TB in over 30 years. Current TB
therapy relies on drugs that are 50 years old and take six to
nine months to complete, making patient compliance very
dif®cult (World Health Organization, 2003).
As a part of the International Co-operative Biodiversity
Group, our program focuses on the search for novel anti-
tubercular principles of plant or microbial origins from the
dry-land biodiversity of Latin America. It is in this regard that
the bioassay-guided chemical investigation of the Chilean
plant Valeriana laxi¯ora DC (Valerianaceae) was initiated.
The methanol extract of V. laxi¯ora was found to be active
against the H37Rv strain (ATCC 27294) of Mycobacterium
tuberculosis, and the bioassay-directed fractionation led to the
isolation of the title compound, (I), an iridolactone, as
previously described (Gu et al., 2004).
X-Ray crystallographic analysis of (I) was initiated to
establish unequivocally its chemical structure and to deter-
mine the absolute and relative stereochemistries of all the
functional groups and the ring junction at atoms C5 and C9.
The two rings are cis-fused, with both atom H5 and atom H9
-oriented, as shown in Fig. 1. The -lactone ring adopts a
slightly twisted half-chair conformation and the cyclopentane
ring adopts an envelope conformation. The hydroxy group at
atom C7 and the hydroxymethyl group at atom C8 both have 
orientations, as does the C4 methyl group.
The unusually long bond distance of 1.572 (7) AÊ between
the bridge atoms C5 and C9 suggests strain in the fused
system. This observation has been made previously for a
closely related iridolactone (Eisenbraun et al., 1981). As
expected in the case of -lactones, differences in the two
CÐO1 bond distances are observed, the C3ÐO1 bond
[1.451 (7) AÊ ] being longer than the C1ÐO1 bond
[1.335 (6) AÊ ] (Cheung et al., 1965).
The C9ÐC1(O2)ÐO1ÐC3 lactone group is almost planar,
with an r.m.s. deviation of 0.0208 AÊ and a maximum deviation
of 0.352 (4) AÊ for atom O1. The C3ÐO1ÐC1ÐO2 torsion
organic compounds
Acta Cryst. (2004). C60, o773±o775 DOI: 10.1107/S0108270104021511 # 2004 International Union of Crystallography o773





A view of (I), shown with 50% probability displacement ellipsoids. H
atoms are shown as spheres of arbitrary radii.
angle is 177.2 (5), showing only a slight deviation from
planarity. This con®guration concurs with that reported for
(+)-nepetalic acid (Eisenbraun et al., 1981) and an iridane-
derived lactone, boonein (Marini-Bettolo et al., 1983).
The packing is dominated by hydrogen bonding, which
creates an in®nite tape of molecules coincident with the 21 axis
(Table 1 and Fig. 2). The C7-hydroxy group of each molecule is
hydrogen bonded through the O3ÐH3 group to the b-trans-
lated neighboring hydroxymethyl atom O4 to form a chain.
Each chain faces another chain of molecules related by the 21
axis, so that the cyclopentane rings of the ®rst chain are facing
the cyclopentane rings of the next. Each C7-hydroxy group is
then also hydrogen bonded through atom O3 to the H4ÐO4
hydroxymethyl group of the molecule facing it, forming a
molecular tape. A solvent-accessible channel along each side
of the tape allows for hydrogen bonding to the chloroform
solvent (Fig. 1). Each molecule of chloroform is hydrogen
bonded through atom H20 to atom O4 of the hydroxymethyl
group. In addition, each carbonyl O2 atom makes short
contacts with atom H5 of an adjacent molecule in the same
tape, as well as to atom H9 of a molecule in an adjoining tape
(see Table 1).
The inclusion of a chloroform solvent molecule in the
crystal structure allowed the anomalous dispersion data to be
used to arrive at the absolute con®guration of (I) as
4R,4aR,6S,7S,7aS. The same absolute con®guration has been
determined by the Mosher ester procedure (Ohtani et al.,
1991), which also unequivocally proves enantiomeric purity
(Gu et al., 2004). Although, we are on the edge of full con®-
dence in our re®nement of the Flack parameter (Flack &
Bernardinelli, 2000), our results are fully consistent with
supporting NMR data from the synthesis of R- and S-MTPA
[-methoxy--(tri¯uoromethyl)phenylacetic acid] esters.
The crystals were isolated as very thin plates, and crystal
decomposition due to evaporation of solvent at room
temperature posed considerable problems in the selection and
mounting of a suitable crystal. Nevertheless, we were able to
obtain important information on the structure, conformation
and absolute con®guration of (I) from this study. This infor-
mation can now be used to predict the three-dimensional
structures of closely related iridolactones isolated as natural
products but which do not crystallize. To our knowledge, this is
the ®rst report of the absolute con®guration of 1-iridolactones
based on X-ray data.
Experimental
The dried and powdered aerial parts and roots of V. laxi¯ora (770 g)
were extracted repeatedly with MeOH. This MeOH extract was
®ltered, the solvent was evaporated under vacuum and the resultant
extract was partitioned between 90% aqueous MeOH and n-hexane.
The 90% aqueous MeOH soluble portion was dried under vacuum
and subsequently partitioned between CH2Cl2 and H2O (1:1). The
CH2Cl2 soluble extract was further fractionated by column chroma-
tography on a silica-gel column using a step gradient of CHCl3/
MeOH. The fraction eluting with 20:1 CHCl3/MeOH (2.2 g) was
chromatographed on a silica-gel column using an n-hexane/i-PrOH/
MeOH step gradient. The fraction eluting with 18:1:1 n-hexane/
i-PrOH/MeOH (370 mg) was applied to a Sephadex LH-20 column,
using MeOH as the mobile phase. The fraction containing (I) (60 mg)
was puri®ed by reverse-phase high-performance liquid chromato-
graphy (RP±HPLC) using CH3CN/H2O (1:1). Compound (I) (14 mg)
was isolated at RF = 0.62 (Gu et al., 2004). Crystals were obtained as
very thin colorless rectangular plates using CHCl3. Crystals were
removed in a drop of the mother liquor using a pipette and trans-
ferred to a drop of paratone oil to seal in the solvent and prevent
evaporation. A suitable crystal was selected and transfered to a glass
®ber, covered by a thin protective ®lm of paratone, and mounted
quickly to prevent solvent loss by evaporation. The paratone oil was
graciously provided by Professor Marilyn Olmstead of the University





a = 10.523 (3) AÊ
b = 6.0404 (15) AÊ
c = 11.231 (3) AÊ
 = 94.478 (5)
V = 711.7 (3) AÊ 3
Z = 2
Dx = 1.491 Mg m
ÿ3
Mo K radiation
Cell parameters from 794
re¯ections
 = 2.6±18.8
 = 0.65 mmÿ1
T = 173 (2) K
Parallelepiped, colorless
0.78  0.09  0.02 mm
Data collection
Bruker SMART CCD area-detector
diffractometer
' and ! scans
Absorption correction: multi-scan
(SADABS; Sheldrick, 2003)
Tmin = 0.268, Tmax = 0.987
6446 measured re¯ections
2420 independent re¯ections




h = ÿ12! 12
k = ÿ7! 7
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Figure 2
The packing geometry of (I), looking at the face of the hydrogen-bonded
tape. Atoms labeled with the suf®xes A and B are at symmetry positions
(ÿx, y + 12, ÿz + 2) and (x, y ÿ 1, z), respectively.
Re®nement
Re®nement on F 2
R[F 2 > 2(F 2)] = 0.062





w = 1/[2(F 2o) + (0.0327P)
2]




max = 0.30 e AÊ
ÿ3
min = ÿ0.26 e AÊ ÿ3
Absolute structure: Flack (1983),
1038 Friedel pairs
Flack parameter = 0.11 (12)
The best available crystal, which was larger than the beam in one
dimension, was used in order to enhance diffraction (GoÈ rbitz, 1999).
Nevertheless, the observed diffraction pattern was weak. H atoms
were easily visible in difference Fourier maps, but all H atoms were
placed at ideal positions and constrained to ride on the atoms to
which they were bonded (CÐH = 0.98±1.00 AÊ ), except for the
hydroxy H atoms, which were constrained to an OÐH distance of
0.84 AÊ and a CÐOÐH angle of 109.5. As a result of the fortuitous
inclusion of a heavy-atom solvent molecule (CHCl3) in the crystal
structure, we were able to use the anomalous dispersion data to arrive
at the absolute con®guration of (I).
Data collection: SMART (Bruker, 1997); cell re®nement: SMART;
data reduction: SAINT (Bruker, 1997); program(s) used to solve
structure: SHELXS97 (Sheldrick, 1997); program(s) used to re®ne
structure: SHELXL97 (Sheldrick, 1997); molecular graphics:
SHELXTL (Bruker, 1997); software used to prepare material for
publication: SHELXTL.
The structure of the title compound was determined in the
Molecular Structure Laboratory of the Department of
Chemistry, University of Arizona. The diffractometer was
obtained with funds provided by the NSF (grant No.
CHE9610374). This study was supported by NIH grant No.
5U01TW00316-10 awarded to BNT.
Supplementary data for this paper are available from the IUCr electronic
archives (Reference: SX1145). Services for accessing these data are
described at the back of the journal.
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Table 1
Hydrogen-bonding and short-contact geometry (AÊ , ).
DÐH  A DÐH H  A D  A DÐH  A
O3ÐH3  O4i 0.84 1.88 2.651 (5) 152
O4ÐH4  O3ii 0.84 1.87 2.654 (4) 156
C20ÐH20  O4 1.00 2.42 3.402 (6) 166
C5ÐH5  O2i 1.00 2.70 3.575 (7) 146
C9ÐH9  O2iii 1.00 2.49 3.188 (6) 127
Symmetry codes: (i) x; yÿ 1; z; (ii) ÿx; 12 y; 2ÿ z; (iii) ÿx; yÿ 12; 1ÿ z.
